Literature DB >> 26959508

Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.

Ling Wang1,2, Juan Zhao1,2, Jun P Ren1,2, Xiao Y Wu1,2, Zheng D Morrison1,2, Mohamed A Elgazzar1, Shun B Ning1,2, Jonathan P Moorman1,2,3, Zhi Q Yao1,2,3.   

Abstract

OBJECTIVE: Regulatory T cells (Tregs) contribute to HIV-1 disease progression by impairing antiviral immunity; however, the precise mechanisms responsible for the development of Tregs in the setting of HIV-1 infection are incompletely understood.
DESIGN: In this study, we provide evidence that HIV-induced expansion of monocytic myeloid-derived suppressor cells (M-MDSCs) promote the differentiation of Foxp3 Tregs.
METHODS: We measured MDSC induction and cytokine expression by flow cytometry and analyzed their functions by coculturing experiments.
RESULTS: We observed a dramatic increase in M-MDSC frequencies in the peripheral blood of HIV-1 seropositive (HIV-1) individuals, even in those on antiretroviral therapy with undetectable viremia, when compared with healthy participants. We also observed increases in M-MDSCs after incubating healthy peripheral mononuclear cells (PBMCs) with HIV-1 proteins (gp120 or Tat) or Toll-like receptor 4 ligand lipopolysaccharides in vitro, an effect that could be abrogated in the presence of the phosphorylated signal transducer and activator of transcription 3 inhibitor, STA-21. Functional analyses indicated that M-MDSCs from HIV-1 individuals express higher levels of IL-10, tumor growth factor-β, IL-4 receptor α, p47, programmed death-ligand 1, and phosphorylated signal transducer and activator of transcription 3 - all of which are known mediators of myelopoiesis and immunosuppression. Importantly, incubation of healthy CD4 T cells with MDSCs derived from HIV-1 individuals significantly increased differentiation of Foxp3 Tregs. In addition, depletion of MDSCs from PBMCs of HIV-1 individuals led to a significant reduction of Foxp3 Tregs and increase of IFNγ production by CD4 T effector cells.
CONCLUSIONS: These results suggest that HIV-induced MDSCs promote Treg cell development and inhibit T cell function - a hallmark of many chronic infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26959508      PMCID: PMC4889474          DOI: 10.1097/QAD.0000000000001083

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  45 in total

1.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

2.  Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients.

Authors:  Johan K Sandberg; Karolin Falconer; Veronica D Gonzalez
Journal:  Virulence       Date:  2010 May-Jun       Impact factor: 5.882

3.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

Authors:  Hui Song; Renxiao Wang; Shaomeng Wang; Jiayuh Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

4.  Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.

Authors:  Thomas Vollbrecht; Renate Stirner; Amanda Tufman; Julia Roider; Rudolf M Huber; Johannes R Bogner; Andreas Lechner; Carole Bourquin; Rika Draenert
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

5.  Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

Authors:  D D Anthony; T Umbleja; J A Aberg; M Kang; K Medvik; M M Lederman; M G Peters; M J Koziel; E T Overton
Journal:  Vaccine       Date:  2011-03-11       Impact factor: 3.641

6.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

7.  Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.

Authors:  Chien-Ying Liu; Yu-Min Wang; Chih-Liang Wang; Po-Hao Feng; How-Wen Ko; Yun-Hen Liu; Yi-Cheng Wu; Yen Chu; Fu-Tsai Chung; Chih-Hsi Kuo; Kang-Yun Lee; Shu-Min Lin; Horng-Chyuan Lin; Chun-Hua Wang; Chih-Teng Yu; Han-Pin Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

8.  Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells.

Authors:  Haishan Li; C David Pauza
Journal:  Retrovirology       Date:  2013-06-06       Impact factor: 4.602

9.  Increased Regulatory T-Cell Percentage Contributes to Poor CD4(+) Lymphocytes Recovery: A 2-Year Prospective Study After Introduction of Antiretroviral Therapy.

Authors:  Julien Saison; Delphine Maucort Boulch; Christian Chidiac; Julie Demaret; Christophe Malcus; Laurent Cotte; Francoise Poitevin-Later; Patrick Miailhes; Fabienne Venet; Mary Anne Trabaud; Guillaume Monneret; Tristan Ferry
Journal:  Open Forum Infect Dis       Date:  2015-05-01       Impact factor: 3.835

10.  Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.

Authors:  Qing-Lei Zeng; Bin Yang; Hong-Qi Sun; Guo-Hua Feng; Lei Jin; Zheng-Sheng Zou; Zheng Zhang; Ji-Yuan Zhang; Fu-Sheng Wang
Journal:  Mol Cells       Date:  2014-01-27       Impact factor: 5.034

View more
  32 in total

1.  Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.

Authors:  Natascha Köstlin; Margit Vogelmann; Bärbel Spring; Julian Schwarz; Judith Feucht; Christoph Härtel; Thorsten W Orlikowsky; Christian F Poets; Christian Gille
Journal:  Immunology       Date:  2017-06-08       Impact factor: 7.397

Review 2.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

Review 3.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 4.  Recent advances in myeloid-derived suppressor cell biology.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Front Med       Date:  2020-09-02       Impact factor: 4.592

5.  Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.

Authors:  Chiara Secondini; Oriana Coquoz; Lorenzo Spagnuolo; Thibaud Spinetti; Sanam Peyvandi; Laura Ciarloni; Francesca Botta; Carole Bourquin; Curzio Rüegg
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 6.  Myeloid-derived suppressor cells coming of age.

Authors:  Filippo Veglia; Michela Perego; Dmitry Gabrilovich
Journal:  Nat Immunol       Date:  2018-01-18       Impact factor: 25.606

7.  Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.

Authors:  Isabela Silva de Castro; Shari N Gordon; Jun Liu; Massimiliano Bissa; Katherine McKinnon; Hung V Trinh; Melvin N Doster; Luca Schifanella; Namal P Liyanage; JinChao Cao; Olivia Cheng; Kathryn Foulds; Mario Roederer; Richard A Koup; Xiaoying Shen; Georgia D Tomaras; David J Venzon; Donald N Forthal; Timothy Fouts; David C Montefiori; Jim Tartaglia; Mangala Rao; Mario Ostrowski; Genoveffa Franchini; Monica Vaccari
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 8.  The Role of Myeloid-Derived Suppressor Cells in Viral Infection.

Authors:  Megan A O'Connor; Jessica L Rastad; William R Green
Journal:  Viral Immunol       Date:  2017-01-04       Impact factor: 2.257

9.  Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.

Authors:  Jun P Ren; Lin Wang; Juan Zhao; Ling Wang; Shun B Ning; Mohamed El Gazzar; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-11-11       Impact factor: 7.397

10.  Residual immune activation in HIV-Infected individuals expands monocytic-myeloid derived suppressor cells.

Authors:  Ritesh Singh; Mouli Chakraborty; Anuradha Gautam; Suman K Roy; Indranil Halder; Jamie Barber; Ankita Garg
Journal:  Cell Immunol       Date:  2021-02-10       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.